5-Carbapenems and Monobactams - 090ct2012

You might also like

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 5

Carbapenems and Monobactams

Pharmacology L3 PHCL-L3-AntiMicro-

Carbapenems
Imipenem, Meropenem, and Ertapenem

Most broad spectrum of activity of all antimicrobials Have activity against gram-positive and gram-negative aerobes and anaerobes Bacteria not covered by carbapenems include MRSA, coagulase-negative staph, C. difficile, Nocardia

Monobactams
Spectrum of Activity

Aztreonam bind preferentially to PBP 3 of gram-negative aerobes; has little to no activity against gram-positives or anaerobes Gram-negative

E. coli, K. pneumoniae, P. mirabilis, H. influenzae, M. catarrhalis, Enterobacter, Citrobacter, Providencia, Salmonella, Shigella and Pseudomonas aeruginosa
3

Carbapenems
Clinical Uses

Hospital acquired infections such as:


respiratory tract infections, septicemia, intraabdominal infections, skin and soft tissue infections, bone and joint infections (not ertapenem if Pseudo)

Polymicrobial infections Empiric therapy


Febrile neutropenia imip and mero Meningitis - meropenem


4

Monobactams
Clinical Uses

Urinary tract infections, respiratory tract infections, meningitis, bacteremia, skin and soft tissue infections, and intraabdominal infections caused by susceptible gram-negatives Penicillin-allergic patients who require antibiotic with gram-negative coverage

You might also like